J 2017

Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia

STUCHLÝ, Jan, Veronika KANDEROVÁ, Marcela VLKOVÁ, Ivana HEŘMANOVÁ, Lucie SLÁMOVÁ et. al.

Základní údaje

Originální název

Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia

Autoři

STUCHLÝ, Jan (203 Česká republika), Veronika KANDEROVÁ (203 Česká republika), Marcela VLKOVÁ (203 Česká republika, domácí), Ivana HEŘMANOVÁ (203 Česká republika), Lucie SLÁMOVÁ (203 Česká republika), Ondřej PELÁK (203 Česká republika), Eli TARALDSRUD (578 Norsko), Dalibor JÍLEK (203 Česká republika), Pavlína KRALÍČKOVÁ (203 Česká republika), Borre FEVANG (578 Norsko), Marie TRKOVÁ (203 Česká republika), Ondřej HRUŠÁK (203 Česká republika), Eva FROŇKOVÁ (203 Česká republika), Anna ŠEDIVÁ (203 Česká republika), Jiří LITZMAN (203 Česká republika, garant, domácí) a Tomáš KALINA (203 Česká republika)

Vydání

Scientific Reports, LONDON, NATURE PUBLISHING GROUP, 2017, 2045-2322

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 4.122

Kód RIV

RIV/00216224:14110/17:00096592

Organizační jednotka

Lékařská fakulta

UT WoS

000391181500001

Klíčová slova anglicky

B-CELLS; CVID PATIENTS; T-CELLS; RHEUMATOID-ARTHRITIS; DIFFERENTIATION; DISEASE; CLASSIFICATION; MUTATIONS; ABNORMALITIES; DEFICIENCY

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 20. 3. 2018 12:09, Soňa Böhmová

Anotace

V originále

Common variable immunodeficiency (CVID) is a heterogeneous group of diseases. Our aim was to define sub-groups of CVID patients with similar phenotypes and clinical characteristics. Using eight-color flow cytometry, we analyzed both B-and T-cell phenotypes in a cohort of 88 CVID patients and 48 healthy donors. A hierarchical clustering of probability binning "bins" yielded a separate cluster of 22 CVID patients with an abnormal phenotype. We showed coordinated proportional changes in naive CD4+ T-cells (decreased), intermediate CD27-CD28+ CD4+ T-cells (increased) and CD21low B-cells (increased) that were stable for over three years. Moreover, the lymphocytes' immunophenotype in this patient cluster exhibited features of profound immunosenescence and chronic activation. Thrombocytopenia was only found in this cluster (36% of cases, manifested as Immune Thrombocytopenia (ITP) or Evans syndrome). Clinical complications more frequently found in these patients include lung fibrosis (in 59% of cases) and bronchiectasis (55%). The degree of severity of these symptoms corresponded to more deviation from normal levels with respect to CD21low B-cells, naive CD4+ and CD27-CD28+ over three years. Moreover, th-cells. Next-generation sequencing did not reveal any common genetic background. We delineate a subgroup of CVID patients with activated and immunosenescent immunophenotype of lymphocytes and distinct set of clinical complications without common genetic background.